PMID: 7489809Aug 1, 1995Paper

Occupational asthma due to ceftazidime

The European Respiratory Journal
S C StentonD J Hendrick


A worker employed in the manufacture of the new third generation cephalosporin antibiotic, ceftazidime, developed asthmatic symptoms, and a series of inhalation challenge tests was undertaken to investigate the problem. The inhalation of increasing daily doses of ceftazidime up to 3.2 mg, using a double-blind challenge protocol gave rise to symptoms, late asthmatic reactions, and increases in airway responsiveness to methacholine. A repeat challenge with the 3.2 mg dose additionally gave rise to a clear immediate reaction. Ceftazidime was, thus, shown to be capable of inducing occupational asthma.


May 6, 2010·Chest·Susana Gómez-OllésXavier Muñoz
May 24, 2011·Journal of Allergy·Sara Díaz AnguloPaul Cullinan
Jan 26, 2007·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M BlancaA DeWeck
Apr 29, 2004·The Journal of Allergy and Clinical Immunology·Hae-Sim ParkChoon-Sik Park
Jul 31, 2016·Toxicological Sciences : an Official Journal of the Society of Toxicology·Sander DikJanine Ezendam
Oct 13, 2009·Chronic Respiratory Disease·S C Stenton
Apr 5, 2011·Allergy, Asthma & Immunology Research·Hyun Jung JinHae-Sim Park
Jul 14, 2000·American Journal of Industrial Medicine·V van KampenX Baur
Nov 9, 2017·American Journal of Industrial Medicine·Rolf MergetThomas Brüning

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.


This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.